March 19, 2026

Sleep Apnea Device Receives FDA Approval

Randomized trial data support the approval, with sustained improvements in apnea severity observed.

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

March 02, 2026

Pediatricians at the Perioperative Helm

Pediatricians “uniquely positioned” to take active role in preanesthesia planning, says revised American Academy of Pediatrics report

Conexiant

September 09, 2025

Dietary Nitrate Lowers Blood Pressure in Older Adults, Study

Researchers show nitrate-rich beetroot reshapes the oral microbiome.

Conexiant

September 26, 2025

FDA Approves First Once-Daily Oral Therapy for Acromegaly

Once-daily paltusotine offers an oral alternative to monthly injections for eligible adults.

Conexiant

January 28, 2026

IPF Cough: Opioid-Based Approach Tested

Researchers examine oral nalbuphine for chronic cough in IPF, using objective digital monitoring and patient-reported measures.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

February 13, 2026

Chronic Cough Despite Normal Workup

Researchers describe diagnostic evaluation and management considerations when standard testing fails to identify the cause of persistent cough.

Conexiant